Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
SUPN on Nasdaq
Charles W. Newhall III - trading volume in the past year for Supernus Pharmaceuticals, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
120K |
$1.55M |
$12.98 |
Nov 21, 2025 |
Direct |
|
|
| Restricted Stock Unit |
4.48K |
$178K |
$39.70 |
Feb 19, 2025 |
Direct |
Common Stock |
|
| Restricted Stock Units |
0 |
$0 |
$39.70 |
Feb 22, 2025 |
Direct |
Common Stock |
|
| Director Stock Option (Right to Buy) |
0 |
|
|
Nov 21, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.